SkinHealth (SKIN) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $0.90 from $1.00 | Aug 12, 2026 |
| Roth Capital | Maintained | Buy | $2.00 from $2.50 | May 20, 2026 |
| Canaccord Genuity | Maintained | Hold | $1.00 from $1.50 | May 1, 2026 |
| TD Cowen | Maintained | Hold | $1.50 from $1.65 | Mar 16, 2026 |
| Canaccord Genuity | Maintained | Hold | $1.50 | Mar 13, 2026 |
| TD Cowen | Maintained | Hold | $1.65 from $1.50 | Jan 21, 2026 |
| Jefferies | Initiated Coverage | Hold | $1.60 | Jan 14, 2026 |
| TD Cowen | Maintained | Hold | $2.50 from $2.00 | Sep 22, 2025 |
| Roth Capital | Initiated Coverage | Buy | $3.50 | Sep 19, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.25 from $1.50 | May 5, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.50 from $1.75 | Mar 13, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.75 from $1.25 | Nov 13, 2024 |
| Canaccord Genuity | Maintained | Hold | $1.25 from $2.00 | Aug 12, 2024 |
| Piper Sandler | Maintained | Underweight | $1.00 from $1.50 | Aug 9, 2024 |
| Stifel | Maintained | Hold | $2.00 from $4.00 | Jul 26, 2024 |
| Piper Sandler | Maintained | Underweight | $1.50 from $2.50 | Jul 11, 2024 |
| TD Cowen | Maintained | Hold | $3.00 from $4.00 | May 13, 2024 |
| DA Davidson | Maintained | Buy | $5.00 | May 13, 2024 |
| Piper Sandler | Maintained | Underweight | $2.50 from $3.00 | May 10, 2024 |
| DA Davidson | Maintained | Buy | $5.00 | Mar 15, 2024 |
Frequently asked questions
Is SKIN a buy, sell, or hold?
Analysts covering SkinHealth currently average a Hold rating: 1 buy, 6 hold and 2 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SKIN?
On Aug 12, 2026, TD Cowen maintained SkinHealth at Hold with a price target of $0.90.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.